Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis

Pediatric Nephrology

Volumn 21, Issue 1, 2006, Pages 110-113

  Levtchenko, Elena N ^a   van Dael, Carin M ^b   de Graaf Hess, Addy C ^a   Wilmer, Martijn J G ^a   van den Heuvel, Lambertus P ^a   Monnens, Leo A ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Compliance; Cysteamine; Cystinosis; Dose regimen

Indexed keywords

CELL PROTEIN; CYSTINE; MERCAPTAMINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTINOSIS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG METABOLISM; FEMALE; HUMAN; KIDNEY FAILURE; MALE; NEUTROPHIL; PATIENT COMPLIANCE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

ADOLESCENT; CHILD; CYSTEAMINE; CYSTINE; CYSTINOSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; NEUTROPHILS; TIME FACTORS;

EID: 29944442542     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2052-0     Document Type: Article

References (17)

1. +-driven lysosomal cystine transporter: EMBO J 20:5940-5949
2. Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18:319-324 10.1038/ng0498-319
3. Gahl W, Thoene JG, Schneider J (2001) Cystinosis: A disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 5085-6108
4. Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 347:111-121 10.1056/NEJMra020552
5. Thoene JG, Oshima RG, Crawhall JC, Olson D, Schneider JA (1976) Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest 58:180-189 932205
6. Pisoni RL, Thoene JG, Christensen HN (1985) Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts: Role of therapeutic cystine removal. J Biol Chem 260:4791-4798 3921538
7. Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman G, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby JG, Sonies BC, Thoene JG, Trauner D, Gahl WA (2005) First NIH/Office of Rare Diseases Conference on Cystinosis: Past, present, and future. Pediatr Nephrol 20:452-454 10.1007/s00467-004-1777-5
8. Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157-1162 10.1056/NEJM199304223281604
9. Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA (2005) Swallowing dysfunction in 101 patients with nephropathic cystinosis: Benefit of long-term cysteamine therapy. Medicine (Baltimore) 84:137-146
10. Smolin LA, Clark KF, Thoene JG, Gahl WA, Schneider JA (1988) A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine content in nephropathic cystinosis. Pediatr Res 23:616-620 3393396
11. Belldina EB, Huang MY, Schneider JA, Brundage RC, Tracy TS (2003) Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients. Br J Clin Pharmacol 56:520-525 10.1046/j.1365-2125.2003.01927.x
12. Smolin LA, Clark KF, Schneider JA (1987) An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes. Am J Hum Genet 41:266-275 3618595
13. Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H (2004) Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy. Clin Chem 50:1686-1688 10.1373/ clinchem.2004.031872
14. De Graaf A, Trijbels F, Blom H (1999) New method for determining cystine in leukocytes and fibroblasts. Clin Chem 45:2224-2228 10585356
15. Schneider JA (2004) Treatment of cystinosis: Simple in principle, difficult in practice. J Pediatr 145:436-438 10.1016/j.jpeds.2004.05.049
16. Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long follow-up of well treated nephropathic cystinosis patients. J Pediatr 145:555-560 10.1016/j.jpeds.2004.03.056
17. Dohil R, Newbury R, Sellers Z, Deutsch R, Schneider JA (2003) The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. J Pediatr 143:224-230 10.1067/ S0022-3476(03)00281-6